Company: IMCR
Filing Date: 2025-03-24
Form Type: PRE 14A
Source: 0001140361-25-010035
Chunk: 23

Company: Immunocore Holdings plc
Filing Date: 2025-03-24
Form: PRE 14A
Chunk 23
---
ANA TO OUR BOARD OF DIRECTORS AS A CLASS I DIRECTOR. 13 TABLE OF CONTENTS RESOLUTION 3 RE-APPOINTMENT OF PROFESSOR SIR PETER RATCLIFFE TO THE BOARD OF DIRECTORS Professor Sir Peter Ratcliffe is currently a member of our board of directors, and has been nominated for re-appointment as a director. If re-appointed, Professor Sir Peter Ratcliffe will hold office from the date of his re-appointment until the 2028 annual general meeting of shareholders, where he must retire by rotation and offer himself for re-appointment, or until his earlier death, resignation or removal. Professor Sir Peter Ratcliffe has agreed to serve if re-appointed, and our board of directors has no reason to believe that he will be unable to serve. Professor Sir Peter Ratcliffe has served on our board of directors since November 2020. Professor Sir Peter Ratcliffe currently serves as the Director of Clinical Research at The Francis Crick Institute in London and Director for the Target Discovery Institute and Distinguished Scholar of the Ludwig Institute for Cancer Research within the Nuffield Department of Medicine at the University of Oxford. Previously, Professor Sir Peter Ratcliffe served as Nuffield Professor and Head of the Nuffield Department of Clinical Medicine from 2004 to 2016. In 2019, Professor Sir Peter Ratcliffe was awarded the Nobel Prize for Physiology or Medicine alongside William G Kaelin, Jr. of Harvard University and Gregg L. Semenza of Johns Hopkins University. In 2002, Professor Sir Peter Ratcliffe was elected to the Fellowship of the Royal Society and to the Academy of Medical Sciences. He is also a member of European Molecular Biology Organization, a foreign honorary member of the American Academy of Arts and Sciences and a Fellow of the American Association for Cancer Research Academy. We believe Professor Ratcliffe’s extensive scientific background qualifies him to serve on our board of directors. Vote Required The affirmative vote of holders representing a simple majority of the total voting rights of shareholders present in person or by proxy who (being entitled to vote) vote on the matter will be required to re-appoint Professor Sir Peter Ratcliffe to our board of directors as a Class I director. THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE RE-APPOINTMENT OF PROFESSOR SIR PETER RATCLIFFE TO OUR BOARD OF DIRECTORS AS A CLASS I DIRECTOR. 14 TABLE OF CONTENTS RESOLUTION 4 ADVISORY VOTE ON EXECUTIVE COMPENSATION Under